Cargando…
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
BACKGROUND: COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677468/ https://www.ncbi.nlm.nih.gov/pubmed/35007996 http://dx.doi.org/10.1016/j.esmoop.2021.100374 |
_version_ | 1784616151666393088 |
---|---|
author | Lim, K.H.J. Murali, K. Thorne, E. Punie, K. Kamposioras, K. Oing, C. O’Connor, M. Élez, E. Amaral, T. Garrido, P. Lambertini, M. Devnani, B. Westphalen, C.B. Morgan, G. Haanen, J.B.A.G. Hardy, C. Banerjee, S. |
author_facet | Lim, K.H.J. Murali, K. Thorne, E. Punie, K. Kamposioras, K. Oing, C. O’Connor, M. Élez, E. Amaral, T. Garrido, P. Lambertini, M. Devnani, B. Westphalen, C.B. Morgan, G. Haanen, J.B.A.G. Hardy, C. Banerjee, S. |
author_sort | Lim, K.H.J. |
collection | PubMed |
description | BACKGROUND: COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals 1 year on since the start of the pandemic. METHODS: An online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index), feeling burnout (single item from expanded Well-Being Index), and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was carried out, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses. RESULTS: Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared with Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared with the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% versus 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%). and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession. CONCLUSION: Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans. |
format | Online Article Text |
id | pubmed-8677468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86774682021-12-17 The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series Lim, K.H.J. Murali, K. Thorne, E. Punie, K. Kamposioras, K. Oing, C. O’Connor, M. Élez, E. Amaral, T. Garrido, P. Lambertini, M. Devnani, B. Westphalen, C.B. Morgan, G. Haanen, J.B.A.G. Hardy, C. Banerjee, S. ESMO Open Original Research BACKGROUND: COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals 1 year on since the start of the pandemic. METHODS: An online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index), feeling burnout (single item from expanded Well-Being Index), and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was carried out, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses. RESULTS: Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared with Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared with the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% versus 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%). and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession. CONCLUSION: Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans. Elsevier 2021-12-17 /pmc/articles/PMC8677468/ /pubmed/35007996 http://dx.doi.org/10.1016/j.esmoop.2021.100374 Text en © 2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Lim, K.H.J. Murali, K. Thorne, E. Punie, K. Kamposioras, K. Oing, C. O’Connor, M. Élez, E. Amaral, T. Garrido, P. Lambertini, M. Devnani, B. Westphalen, C.B. Morgan, G. Haanen, J.B.A.G. Hardy, C. Banerjee, S. The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series |
title | The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series |
title_full | The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series |
title_fullStr | The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series |
title_full_unstemmed | The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series |
title_short | The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series |
title_sort | impact of covid-19 on oncology professionals—one year on: lessons learned from the esmo resilience task force survey series |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677468/ https://www.ncbi.nlm.nih.gov/pubmed/35007996 http://dx.doi.org/10.1016/j.esmoop.2021.100374 |
work_keys_str_mv | AT limkhj theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT muralik theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT thornee theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT puniek theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT kamposiorask theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT oingc theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT oconnorm theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT eleze theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT amaralt theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT garridop theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT lambertinim theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT devnanib theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT westphalencb theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT morgang theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT haanenjbag theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT hardyc theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT banerjees theimpactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT limkhj impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT muralik impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT thornee impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT puniek impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT kamposiorask impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT oingc impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT oconnorm impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT eleze impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT amaralt impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT garridop impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT lambertinim impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT devnanib impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT westphalencb impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT morgang impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT haanenjbag impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT hardyc impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries AT banerjees impactofcovid19ononcologyprofessionalsoneyearonlessonslearnedfromtheesmoresiliencetaskforcesurveyseries |